| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $219.0M | +2.1% |
| Cost of Revenue | $70.4M | -1.6% |
| Gross Profit | $148.6M | +3.9% |
| R&D Expense | $41.7M | -12.0% |
| SG&A Expense | $55.6M | +4.8% |
| Operating Income | -$27.1M | -3.8% |
| Pre-tax Income | -$11.7M | +55.3% |
| Income Tax | $2.7M | -38.3% |
| Net Income | -$14.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.5M | +52.3% |
| Accounts Receivable | $65.1M | +15.0% |
| Inventory | $12.1M | +16.5% |
| Current Assets | $197.5M | +5.6% |
| Total Assets | $335.1M | -2.1% |
| Current Liabilities | $110.8M | +24.4% |
| Total Liabilities | $131.8M | +7.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | -110.8% |
| Capital Expenditures | $5.0M | +130.3% |
| Investing Cash Flow | $46.6M | +524.3% |
| Financing Cash Flow | -$7.3M | +29.7% |
| Free Cash Flow | -$10.8M | -119.4% |
| +52.8% |
| EPS (Basic) | -$0.36 | +53.2% |
| EPS (Diluted) | -$0.36 | +53.2% |
| Stockholders' Equity |
| $203.3M |
| -7.5% |